Technology
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Originally published on TechCrunch
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
This article continues with more details and analysis.
Share: